Expression of CD31 by cells of extensive ductal in situ and invasive carcinomas of the breast
โ Scribed by Anna Sapino; Massimo Bongiovanni; Paola Cassoni; Luisella Righi; Riccardo Arisio; Silvia Deaglio; Fabio Malavasi
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 515 KB
- Volume
- 194
- Category
- Article
- ISSN
- 0022-3417
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Background: More than 50% of breast ductal carcinomas in situ (dcis) contain significant histologic necrosis, an important prognostic factor for determining recurrence and progression to invasive breast cancer. we have examined whether the mechanism of this spontaneous cell death might be apopto
Although ductal carcinoma in situ (DCIS) of the breast is accepted as a potential precursor lesion for invasive ductal cancer (IDC), the critical genetic events associated with the tumor progression remain unknown. Since some extensive DCIS may show a small focus of IDC, these cases seem to be parti
Angiogenesis is essential for tumour growth and important in metastasis and for prognosis in invasive carcinoma of the breast. Two patterns of increased vascularity have been shown in mammary ductal carcinoma in situ (DCIS): a cuff of vessels close to the involved ducts, and vessels in the interduct
MUC1 mucin is a high molecular weight transmembrane glycoprotein expressed on the apical cell surface of normal glandular epithelia. In many human adenocarcinomas, this protein is up-regulated and/or underglycosylated, and its expression changes from apical to the entire cell membrane. It is thought